- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04152213
The Effects of Low Glycemic Index (GI) Diet on Cardiometabolic Outcomes Among Obese Chinese Adults
The Effects of Low Glycemic Index (GI) Diet on Cardiometabolic Outcomes Among Obese Chinese Adults: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
29.9% of persons aged 15-84 in Hong Kong are obese. Obesity poses significant detrimental consequences for one's health. Obese patients have an increased risk of mortality when compared with people with normal BMI. Obesity results in arterial hypertension, hyperlipidaemia, heart disease and type 2 diabetes. Low GI diets have been investigated for their impact on weight control. Evidence showed that low GI diets were effective in lowering body mass index. However, the evidence was usually generated from Western populations, thus excluding the influence of Chinese culture on diet.The aim of this study is to investigate the effects and the acceptability of low GI diet versus a conventional healthy diet on the BMI and other cardiometabolic risk factors of obese Chinese adults in Hong Kong.
A prospective, two-arm randomized-controlled trial will be conducted to examine the effect of a low GI diet education program on cardiometabolic outcomes in Chinese adults with obesity. The intervention group will receive a low GI diet education, including a one-off, 60-minute, face-to-face, educational session conducted by the research nurse for GI knowledge input. An informational booklet will be given out during the education session.Three follow-up telephone calls of fifteen minutes will be conducted by the research nurse at the 2nd, 5th , and 8th weeks after completing the face-to-face education session. While the control group will receive an education pamphlets on obesity and balanced diet.Three follow-up telephone calls of fifteen minutes will be conducted by the research nurse at the 2nd, 5th , and 8th weeks after receiving the pamphlets.
At baseline, demographic and clinical data, including BMI, waist circumference, body fat, blood pressure, fasting plasma glucose, HbA1c, lipid profile, 3-day food diary, International Physical Activity Questionnaire (IPAQ-C), and the sense of fullness will be collected.
On the 12th week, data about the BMI, waist circumference, body fat, blood pressure, fasting plasma glucose, HbA1c, lipid profile, 3-day food diary, IPAQ-C, and the sense of fullness and a questionnaire on the evaluation process will be collected.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- District Councilor Office
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI >25.0 kg/m2;
- Waist circumference > 90 cm for men and > 80 cm for women;
- Aged eighteen years or older;
- Chinese ethnicity;
- Can be contacted by telephone;
- Have the ability to read and understand Chinese; and
- Can provide informed consent.
Exclusion Criteria:
- Concurrently participating in any other clinical trials;
- Concurrently participating in weight control programs;
- Concomitant intake of weight reduction drugs;
- Use of calorie restricted diet or specialized diets which contraindicated with low GI diet;
- Have gastrointestinal problems that would prevent them from following the prescribed diet.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Low GI diet group
The components of the Low GI diet group include: (1) A one-off, 60-minute, face-to-face, educational session conducted by the research nurse for GI knowledge input. (2) An informational booklet will be given out during the education session. (3) Three follow-up telephone calls of fifteen minutes will be conducted by the research nurse at the 2nd, 5th , and 8th weeks after completing the face-to-face education session. |
This educational session will cover information on obesity, complications of obesity, the benefit of weight loss, the glycemic index and its associated low GI diet, a food-exchange table including high- to low-GI foods, and self-decision in food choices.
The dietary advice will be based on the standard food pyramid for the conventional Chinese diet as promoted by the Hong Kong Department of Health, with an emphasis on the selection of low-GI products.
Practical tips will be given such as the selection of low-GI rice and rice products, the impact of cooking methods (including cooking time, cooking conditions, and cooking liquid volume) on rice GI, intervention to reduce the GI of rice, and listing low-GI food options and meal plans.
|
PLACEBO_COMPARATOR: Control group
The components of the control group include: (1) Pamphlets from the Department of Health about obesity and a balanced diet based on the food pyramid will be distributed. (2)Three follow-up telephone calls of fifteen minutes will be conducted by the research nurse at the 2nd, 5th , and 8th weeks after receiving the pamphlets. |
This educational session will cover information on obesity, complications of obesity, the benefit of weight loss, the glycemic index and its associated low GI diet, a food-exchange table including high- to low-GI foods, and self-decision in food choices.
The dietary advice will be based on the standard food pyramid for the conventional Chinese diet as promoted by the Hong Kong Department of Health, with an emphasis on the selection of low-GI products.
Practical tips will be given such as the selection of low-GI rice and rice products, the impact of cooking methods (including cooking time, cooking conditions, and cooking liquid volume) on rice GI, intervention to reduce the GI of rice, and listing low-GI food options and meal plans.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body mass index (BMI)
Time Frame: baseline and 12th week
|
within- and between-participant changes in BMI, BMI is defined as the body mass divided by the square of the body height, and is expressed in units of kg/m^2, resulting from body mass in kilograms(kg) and body height in metres(m).The body mass and body height will be assessed using an electronic scale and a wall-mounted stadiometer, respectively.
|
baseline and 12th week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
waist circumference
Time Frame: baseline and 12th week
|
within- and between-participant changes in waist circumference.
Waist circumference will be measured by using the midway point between the top of the hip bone and base of the ribs as a landmark in centimeters(cm) on bare skin at the end of a normal expiration, with arms relaxed at the sides
|
baseline and 12th week
|
body fat
Time Frame: baseline and 12th week
|
within- and between-participant changes in body fat.
Body fat percentage (%) and different body compositions (visceral fat, subcutaneous whole body, subcutaneous trunk, subcutaneous arms, subcutaneous legs) will be assessed by body composition analyser based on the principles of bioelectrical impedance
|
baseline and 12th week
|
blood pressure
Time Frame: baseline and 12th week
|
within- and between-participant changes in blood pressure.
Blood pressure is measured in terms of the systolic pressure over diastolic pressure and is measured in millimeters of mercury (mmHg)
|
baseline and 12th week
|
fasting plasma glucose
Time Frame: baseline and 12th week
|
within- and between-participant changes in fasting plasma glucose.
Fasting plasma glucose will be drawn by venipuncture after an eight-hour overnight.
fast for laboratory testing.
Fasting plasma glucose is measured in millimoles per liter (mmol/L)
|
baseline and 12th week
|
Hemoglobin A1c (HbA1c)
Time Frame: baseline and 12th week
|
within- and between-participant changes in HbA1c.
HbA1c will be drawn by venipuncture after an eight-hour overnight fast for laboratory testing.
HbA1c will be measured in percentage (%)
|
baseline and 12th week
|
Total cholesterol (TC)
Time Frame: baseline and 12th week
|
within- and between-participant changes in Total cholesterol (TC).
It will be drawn by venipuncture after an eight-hour overnight fast.
It will be measured in millimoles per liter (mmol/L)
|
baseline and 12th week
|
HDL-cholesterol (HDL-C)
Time Frame: baseline and 12th week
|
within- and between-participant changes in HDL-cholesterol (HDL-C).
It will be drawn by venipuncture after an eight-hour overnight fast.
It will be measured in millimoles per liter (mmol/L)
|
baseline and 12th week
|
LDL-cholesterol (LDL-C)
Time Frame: baseline and 12th week
|
within- and between-participant changes in LDL-cholesterol (LDL-C) level.
It will be drawn by venipuncture after an eight-hour overnight fast.
It will be measured in millimoles per liter (mmol/L)
|
baseline and 12th week
|
Triglycerides level (TG)
Time Frame: baseline and 12th week
|
within- and between-participant changes in triglycerides level (TG).
It will be drawn by venipuncture after an eight-hour overnight fast.
It will be measure in millimoles per liter (mmol/L)
|
baseline and 12th week
|
dietary glycemic index (GI) value
Time Frame: baseline and 12th week
|
within- and between-participant changes in dietary GI value.
The dietary GI value for each participant will be calculated by summing the products of the percentage contribution of each individual food to daily available carbohydrate intake multiplied by the food's GI value.
|
baseline and 12th week
|
dietary glycemic load
Time Frame: baseline and 12th week
|
within- and between-participant changes in dietary glycemic load.
The dietary GL will be calculated by multiplying the dietary GI by the total amount of daily available carbohydrate intake.
Dietary will be measured as g per 1000 kcal
|
baseline and 12th week
|
calories
Time Frame: baseline and 12th week
|
within- and between-participant changes in calories [kcal] intake
|
baseline and 12th week
|
carbohydrates
Time Frame: baseline and 12th week
|
within- and between-participant changes in carbohydrates[g] intake
|
baseline and 12th week
|
fat
Time Frame: baseline and 12th week
|
within- and between-participant changes in fat [g] intake
|
baseline and 12th week
|
proteins
Time Frame: baseline and 12th week
|
within- and between-participant changes in proteins[g] intake
|
baseline and 12th week
|
fiber
Time Frame: baseline and 12th week
|
within- and between-participant changes in fiber[g] intake
|
baseline and 12th week
|
the sense of fullness as dietary satiety
Time Frame: baseline and 12th week
|
within- and between-participant changes in the sense of fullness as dietary satiety.
The sense of satiety with diet will be assessed by a visual analogue scale (VAS) consisting of a 100mm long line with the left anchor representing "very hungry" and the right anchor representing "very full."
The satiety premeal, postmeal and 2 hours postmeal will be measured.
|
baseline and 12th week
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
International Physical Activity Questionnaire (IPAQ-C)
Time Frame: baseline and 12th week
|
9 items among four domains on the health-related physical activity.
A summary score of metabolic equivalent task/min per week and a categorical score of physical activity (low, moderate and high) will be used to determine the physical activity level of the participants.
Physical activity are categories three level: low, moderate and high
|
baseline and 12th week
|
self-administer questionnaire
Time Frame: 12th week
|
process evaluation with open-ended questions to identify the acceptability, perceived barriers and experience of low GI diet from participants' perspective
|
12th week
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Sek Ying Chair, The Nethersole School of Nursing, The Chinese University of Hong Kong
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00000000 (Other Identifier: UCDavis IRB exempt)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Istituto Auxologico ItalianoRecruiting
Clinical Trials on Low GI diet
-
Ohio State UniversityRecruitingGlucose Metabolism Disorders | Spinal Cord Injuries | Postprandial HypotensionUnited States
-
University of CopenhagenThe Danish Dairy Research Foundation, Denmark; Nordea-Fonden, Denmark; LEGO Charity... and other collaboratorsActive, not recruitingObesity | Pregnancy | Gestational Age and Weight Conditions | Maternal Care for Excessive Fetal Growth | Metabolic DisordersDenmark
-
Federal University of VicosaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...CompletedType 2 Diabetes MellitusBrazil
-
Maastricht University Medical CenterUnilever R&DCompletedObesity | Diet, Healthy | Fatty Liver, NonalcoholicNetherlands
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Diseases | OverweightUnited States
-
University of TorontoCompletedGestational DiabetesCanada
-
Isfahan University of Medical SciencesCompletedDiabetic Nephropathy | Medication ComplianceIran, Islamic Republic of
-
University of Massachusetts, WorcesterCompletedLow-GI Dietary Education | ADA Dietary EducationUnited States
-
Peking Union Medical College HospitalUnknown
-
University Hospital of the West IndiesCompletedInflammation | Cardiovascular Disease | Type 2 DiabetesJamaica